Publications

Publications

PRI Publications

 

  1. Shiovitz, T.M.; Wilcox, C.S.; Gevorgyan, L. and Shawkat, A. CNS Sites Cooperate to Detect Duplicate Subjects with a Clinical Trial Subject Registry. Innovations in Clinical Neuroscience 10(2); 17-21, February 2013.
     
  2. Wilcox, C.S.; Noble E.P. and Oskooilar, N. ANKK1/DRD2 Locus Variants Are Associated With Rimonabant Efficacy in Aiding Smoking Cessation: Pilot Data. Journal of Investigative Medicine 59(8) 1280-1283, December 2011.
     
  3. Wilcox, C.S.; Oskooilar, N.; Erickson, J.; Billes, S.J.; Katz, B.; Tollefson, G. and Dunayevich, E. An Open-Label Study of Naltrexone and Bupropion Combination Therapy for Smoking Cessation in Overweight and Obese Subjects.  Addictive Behaviors 25: 229-234, 2010.

     
  4. Oskooilar, N.; Wilcox, C.S.; Tong, M. and Grosz, D.E. Body Mass Index and Response to Antidepressants in Depressed Research Subjects. Journal of Clinical Psychiatry 70:11, 1609-1610, November 2009.
     
  5. Oskooilar, N. The Reliability of DSM (letter to the editor). Psychiatry 2006, March: 22-23.
     
  6. Oskooilar, N. A Case of Premature Ventricular Contraction with Modafinil (letter). American Journal of Psychiatry 162: 1984, 2005.
     
  7. Oskooilar, N. Apathy and the DSM V (letter). Clinical Psychiatry News Vol. 33, No. 7: 12, 2005.
     
  8. Oskooilar, N. Treatment Approaches to Phobia (letter). Clinical Psychiatry News Vol. 33, No. 5: 27, 2005.
     
  9. Oskooilar N. Number of Selves (letter). The Psychiatric Times Vol. 22, No. 4; 15-16, 2005.
     
  10. Feiger, A.D.; Heiser, J.F.; Shrivastava, R.K.; Weiss, K.J.; Smith, W.T.; Sitsen, J.M.A. and Gibertini, M. Gepirone Extended-Release: New Evidence for Efficacy in the Treatment of Major Depressive Disorder. J. Clin. Psychiatry; 64:243-249, 2003.

  11. Gottschalk, L.; De Francisco, D.; Bechtel, R. “Computerized Content Analysis of Some Adolescent Letters of Napoleon Bonaparte: A Test of the Validity of the Method,” Journal of Nervous and Mental Diseases, Vol. 190, No. 8, 2002.

  12. Spierings, E.L.H.; Gomez-Mancilla, B.; Grosz, D.E.; Rowland, C.R.; Whaley, F.S. and Jirgens, K.J.: Oral Almotriptan vs Oral Sumatriptan in the Abortive Treatment of Migraine: A Double-blind, Randomized, Parallel-Group, Optimum-Dose Comparison. Archives of Neurology, 58: 944-950, June 2001.

  13. Grosz, D.E.; Morrissey, J.L. and Wilcox, C.S. Comparative Effectiveness of Triptans for the Treatment of Migraine, Today's Therapeutic Trends 20(2): 97-112, 2002.

  14. Thase, M.E.; Ferguson, J.M., Lydiard, R.B. and Wilcox, C.S. Citalopram Treatment of Paroxetine- Intolerant Depressed Patients, Depression and Anxiety. 16: 128-133, 2002.

  15. Wilcox, C.S.; Linden, R.D.; D'Amico, M.F.; De Francisco, D.F.; Morrissey, J.L. and Heiser, J.F. Nefazodone in the Treatment of Elderly Patients with Depression, Today's Therapeutic Trends 20(2): 183-196, 2002.

  16. De Francisco, D. In the Long Run, We are All Dead, Solve the Organ Shortage: Let the Bidding Begin, American Journal of Forensic Psychiatry Vol. 22, No. 2, pp. 52-57, 2001.

  17. De Francisco, D.F. A Physician's Experience as Both a Researcher and a Clinician [Invited Paper, Special Report: Research Issues] Psychiatric Times XVII(6): 57-60, June 2000.

  18. De Francisco, D.F. The Greater the Artistry, the Greater the Danger, Violence in the Media: A Symposium, American Journal of Forensic Psychiatry Vol. 21, No. 4, pp. 27-29, 2000.

  19. Feiger, A.D.; Bielski, R.J.; Bremner, J.; Heiser, J.F.; Trivedi, M.; Wilcox, C.S.; Roberts D.L.; Kensler, T.T.; McQuade, R.D.; Kaplita, S.B. and Archibald, D.G. Double-Blind, Placebo-Substitution Study of Nefazodone in the Prevention of Relapse During Continuation Treatment of Outpatients with Major Depression. International Clinical Psychopharmacology 1999, 14: 19-28.

  20. Heiser, J.F. and Wilcox, C.S. 5HT1A Receptor Agonists as Antidepressants: Pharmacological Rationale and Evidence for Efficacy. CNS Drugs 10(5): 343-353, November 1998.

  21. Schneider, A.L. and Wilcox, C.S. Combined Therapies in the Treatment of Rapid Cycling Lithium Resistant Mania in Geriatric Patients. Journal of Affective Disorders 47: 201-205, 1998.

  22. Lahmeyer, H.; Wilcox, C.; Kann, J. and Leppik, I. Subjective Efficacy of Zolpidem in Outpatients with Chronic Insomnia. Clinical Drug Investigation 12(3): 134-144, March 1997.

  23. Wilcox, C.S.; Ferguson, J.M.; Dale, J.L. and Heiser, J.F. A Double-Blind Trial of a Low Dose Range and High Dose Range of Gepirone-ER Compared to Placebo in the Treatment of Depressed Outpatients Psychopharmacology Bulletin 32(3): 335-342, 1996.

  24. Walczak, D.D.; Apter, J.T.; Halikas, J.A.; Borison, R.L.; Carman, J.S.; Post, G.L.; Patrick, R.; Cohn, J.B.; Cunningham, L.A.; Rittberg, B.; Preskorn, S.H.; Kang, J.S. and Wilcox, C.S. The Oral Dose-Effect Relationship for Fluvoxamine: A Fixed-Dose Comparison Against Placebo in Depressed Outpatients. Annals of Clinical Psychiatry 8(3): 139-151, September 1996.

  25. Wilcox, C.S.; Katz, B.B.; Morgan, D.L.; Morrissey, J.L.; Schneider, A.L. and De Francisco, D.F. Increasing Ethnic Diversity and Managed Care: How Will They Influence Research Patient Recruitment in the 1990s? Psychopharmacology Bulletin 32(2): 193-200, 1996.

  26. Feiger, A.; Kiev, A.; Shrivastava, R.K.; Wisselink, P.G. and Wilcox, C.S. Nefazodone Versus Sertraline in Outpatients with Major Depression: Focus on Efficacy, Tolerability, and Effects on Sexual Function and Satisfaction. Journal of Clinical Psychiatry (57): January 1996.

  27. Adams, J.B.; Pyke, R.E.; Costa, J.; Cutler, N.R.; Schweizer, E.; Wilcox, C.S.; Wisselink, P.G.; Greiner, M; Pierce, M.W. and Pande, A.C. A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients with Generalized Anxiety Disorder. The Journal of Clinical Psychopharmacology 15(6): 428-434, December 1995.

  28. Wilcox, C.S.; Heiser, J.F.; Crowder, A.M.; Wassom, N.J.; Katz, B.B. and Dale, J.L. Comparison of the Effects on Pupil Size and Accommodation of Three Regimens of Topical Dapiprazole. British Journal of Ophthalmology 79(6): 544-548, June 1995.

  29. Wilcox, C.S.; Cohn, J.B.; Katz, B.B.; Mijares, C.P.; Guarino, J.J.; Panagides, J. and De Francisco, D. A Double-Blind, Placebo-Controlled, Study Comparing Mianserin and Amitriptyline in Moderately Depressed Outpatients. International Clinical Psychopharmacology 9: 271-279, Winter 1994.

  30. Shrivastava, R.K.; Cohn, C.; Crowder, J.; Davidson, J.; Dunner, D.; Feighner, J.; Kiev, A. and Patrick, R. Long-Term Safety and Clinical Acceptability of Venlafaxine and Imipramine in Outpatients with Major Depression. Journal of Clinical Psychopharmacology 14/5: 322-329, October 1994.

  31. Heiser, J.F. and Wilcox, C.S. "Book Review" Human Psychopharmacology – Measures and Methods, Volume 4, I. Hindmarch and P.D. Stonier (editors), The Annals of Pharmacotherapy 28: 1205, October 1994.

  32. Cunningham, L.A.; Borison, R.L.; Carman, J.S.; Chouinard, G.; Crowder, J.E.; Diamond, B.I.; Fischer, D.E. and Hearst, E. A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression. Journal of Clinical Psychopharmacology 14: 99-106, April 1994.

  33. Cunningham, L.A.; Borison, R.L.; Carman, J.S.; Chouinard, G.; Crowder, J.E.; Diamond, B.I.; Fischer, D.E. and Hearst, E. A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression. Journal of Clinical Psychopharmacology 14: 99-106, April 1994.

  34. Wilcox, C.S.; Ryan, P.J.; Morrissey, J.L.; Cohn, J.B.; De Francisco, D.F.; Linden, R.D. and Heiser, J.F. A Fixed-Dose Study of Adinazolam-SR Tablets in Generalized Anxiety Disorder. Prog. Neuro-Psychopharmacol. & Biol. Psychiat 18: 979-993, 1994.

  35. Cohn, J.B.; Wilcox, C.S. and Goodman, L.I. Antidepressant Efficacy and Cardiac Safety of Trimipramine in Patients with Mild Heart Disease. Clinical Therapeutics 15 (No.1): 114-126, 1993.

  36. Gammans, R.E.; Stringfellow, J.C.; Hvizdos, A.J.; Seidehamel, R.J.; Cohn, J.B.; Wilcox, C.S.; Fabre, L.F.; Pecknold, J.C.; Smith, W.T. and Rickels, K. Use of Buspirone in Patients with Generalized Anxiety Disorder and Coexisting Depressive Symptoms: A Meta-Analysis of Eight Randomized, Controlled Studies. Neuropsychobiology 25: 193-201, 1992.

  37. Cohn, J.B. (ed.) DEMENTIA. Annotated Bibliography of the Dementia-Associated Diseases and Diagnostic Tests. A Professional Medical and Psychological Reference. Laguna Hills: American Journal of Forensic Psychiatry, 1992.

  38. Cohn, J.B.; Wilcox, C.S. and Morrissey, J.L. Differentiating Delirium from Dementia. American Journal of Forensic Psychiatry 13(4): 3-25, 1992.

  39. Wilcox, C.S.; Cohn, J.B.; Linden, R.D.; Heiser, J.F.; Lucas, P.B.; Morgan, D.L. and De Francisco, D. Predictors of Placebo Response: A Retrospective Analysis. Psychopharmacology Bulletin 28(2): 157-162, 1992.

  40. Dunner, D.L.; Cohn, J.B.; Walshe III, T.; Cohn, C.K.; Feighner, J.P.; Feive, R.R.; Halikas, J.P.; Hartford, J.T.; Hearst, E.D.; Settle, E.C.; Menolascino, F.J. and Muller, D.J. Two Combined, Multicenter, Double-Blind Studies of Paroxetine and Doxepin in Geriatric Patients with Major Depression. J. Clin. Psychiatry 53:2 (suppl), February 1992.

  41. Cohn, J.B. and Wilcox, C.S. Paroxetine in Major Depression: A Double-Blind Trial with Imipramine and Placebo. Journal of Clinical Psychiatry 53:2(suppl): 52-56, February 1992.

  42. Cohn, J.B.; Wilcox, C.S.; Bowden, C.L.; Fisher, J.G. and Rodos, J.J. Double-Blind Comparison of Buspirone and Clorazepate in Anxious Outpatients With and Without Depressive Symptoms. Psychopathology 25(S1): 10-21, 1992.

  43. Dunbar, G.C.; Cohn, J.B.; Fabre, L.F.; Feighner, J.P.; Fieve, R.R.; Mendels, J. and Shrivastava, R.K. A Comparison of Paroxetine, Imipramine and Placebo in Depressed Outpatients. British Journal of Psychiatry 159: 394-398, 1991.

  44. Cohn, J.B.; Wilcox, C.S. and Lerer, B.E. Development of an "Early" Detection Battery for Dementia of the Alzheimer Type. Progress in Neuropsychopharmacology & Biological Psychiatry 15: 433-479, 1991.

  45. Cohn, J.; Claghorn, J. and Ostrow, D. A Comparative Trial of Trimipramine and Doxepin in Depressed Elderly Patients. Advances in Therapy® Vol. 8, No. 2, pp. 92-102, March/April 1991.

  46. Cohn, J.B.; Wilcox, C.S.; Bremner, J. and Ettinger, M. Hypnotic Efficacy of Estazolam Compared with Flurazepam in Outpatients with Insomnia. Journal of Clinical Pharmacology 31(8): 747-750, August 1991. 

  47. Ferguson, J.M.; Bielski, R.J.; Houston, J.; Post, G.L.; Crowder, J.E.; Bailey, L.; Pearlman, H.G.; Shu, V.S. and Pearce, M. W. Comparison of Estazolam and Placebo in the Outpatient Treatment of Insomnia Associated with Major Depression. Current Therapeutic Research 49: 898-907, May 1991.

  48. Cohn, J.B.; Crowder, J.E.; Wilcox, C.S. and Ryan, P.J. A Placebo- and Imipramine-Controlled Study of Paroxetine. Psychopharmacology Bulletin 26(2): 185-189, 1990.

  49. Cohn, J.B. Trial and Error: Confessions of a Courtroom Psychiatrist. American Journal of Forensic Psychiatry Vol. 11, No. 2, pp 1-7, Summer 1990.

  50. Cohn, J.B.; Katon, W. and Richelson, E. Choosing the Right Antidepressant. Patient Care, Vol. 24, No. 12, 88-98, July 15, 1990.

  51. Wilcox, C.S.; Crowder, J.E.; Ryan, P.J.; Schwartz, R. and Hyde, G.L. Oral Pentoxifylline (Trental) in Diabetic Patients with Intermittent Claudication. European Journal of Pharmacology 183/4: 1291-1292, July 1990.

  52. Wilcox, C.S.; Cohn, J.B.; Crowder, J.E. and Ryan, P.J. Patient Motivation and Placebo Response. Journal of Clinical Research and Pharmacoepidemiology 4(2): 154, June 1990. 

  53. Cohn, J.B. On the Practicalities of Being an Expert Witness. American Journal of Forensic Psychiatry Vol. 11, No. 2, 11-20, June 1990.

  54. Blum, K.; Noble, E.P.; Sheridan, P.J.; Montgomery, A.; Ritchie, T.; Jagadeeswaran, P.; Nogami, H.; Briggs, A.H. and Cohn, J.B. Allelic Association of the Human Dopamine D2 Receptor Gene in Alcoholism. Journal American Medical Association Vol. 263, No. 15, 2055-2060, April 1990.

  55. Cohn, J.B.; Collins, G.; Ashbrook, E. and Wernicke, J.F. A Comparison of Fluoxetine, Imipramine and Placebo in Patients with Bipolar Depressive Disorder. International Clinical Psychopharmacology Vol. 4, 313-322, 1989.

  56. Feighner, J.P. and Cohn, J.B. An Analysis of Individual Symptoms in Generalized Anxiety - A Pooled, Multi-Study, Double-Blind Evaluation of Buspirone. Neuropsychobiology Vol. 21, No.3, 124-130, December 1989. 

  57. Crowder, J.E.; Cohn, J.B.; Savitsky, J.P.; Morgan, D.L.; Slywka, J.; Cobert, B.L.; Hryniewicki, S.W.; Piccirillo, R.T. and Wilcox, C.S. Efficacy and Safety of Pentoxifylline in Geriatric Patients with Intermittent Claudication. Angiology: The Journal of Vascular Diseases 40(9): 795-802, September 1989. 

  58. Cohn, J.B. A Comparative Study of the Central Nervous System Effects of Betaxolol vs. Timolol. Letter to the Editor: Archives of Ophthalmology Vol. 107: 633-634, May 1989.

  59. Cohn, J.B. and Rickels, K. A Pooled Double-Blind Comparison of the Effects of Buspirone, Diazepam and Placebo in Women with Chronic Anxiety. Current Med. Research & Opinion 11(5): 304-320, 1989. 

  60. Cohn, J.B. and Wilcox, C.S. Baixo Potencial de Sedacao da Buspirona Comparado com Alprazolam e Lorazepam no Tratamento de Pacientes com Anxiedade: Um Estado Duplo-Cego. Revista Brasileira de Medicina Vol. 46, Nos. 1/2, Jan/Feb, 1989.

  61. Cohn, J.B.; Pyke, R.E. and Wilcox, C.S. Adinazolam Mesylate and Placebo in Depressed Outpatients. Psychiatry Digest pp. 13-14, December 1988.

  62. Cohn, J.B.; Pyke, R.E. and Wilcox, C.S. Adinazolam Mesylate and Placebo in Depressed Outpatients: A 6-Week Double-Blind Comparison. Journal of Clinical Psychiatry 49(4): 142-147, 1988.

  63. Cohn, J. Long-Term Studies of Buspirone. IM-Internal Medicine for the Specialist (Nov. special issue): 21-22, 1987.

  64. Cohn, J.B. and Wilcox, C.S. Diagnostic Criteria for Alzheimer's Disease: An Evaluation. Geriatric Medicine Today 6(61): 77-88, June 1987.

  65. Cohn, J.B. and Wilcox, C.S. Buspirone: Effectiveness, Safety and Mechanisms of Action. IM-Internal Medicine for the Specialist 8(1): 216-224, January 1987.

  66. Cohn, J.B. and Wilcox, C.S. Low-Sedation Potential of Buspirone Compared with Alprazolam and Lorazepam in the Treatment of Anxious Patients: A Double-Blind Study. Journal of Clinical Psychiatry 47(8): 409-412, August 1986.

  67. De Francisco, D. Kohut's Enhancement of Clinical Psychoanalysis. Psychiatric Annals August 1986. 

  68. Cohn, J.B.; Kiev, A.; Potter, W.Z. and Rudorfer, M.V. (Edited by Ethelyn Fuller). When to Use the New Antidepressants. Patient Care 20: 21-55, March 15, 1986. 

  69. Cohn, J.B.; Wilcox, C.S. and Meltzer, H.Y. Neuroendocrine Effects of Buspirone in Patients with Generalized Anxiety Disorder. American Journal of Medicine 80(suppl. 3B): 36-40, March 1986.

  70. Cohn, J.B.; Goa, K.L. and Ward, A. Clinical Trials Section. Buspirone, A Preliminary Review of Its Pharmacological Properties and Therapeutic Efficacy as an Anxiolytic. Drugs 32: 114-129, 1986.

  71. Cohn, J.B. and Wilcox, C.S. Praxilene in the Treatment of Senile Dementia. Conservative Therapy of Arterial Occlusive Disease G. Trubestein (ed.), Georg Thieme Verlag Stuttgart, New York, pp. 330-333, 1986.

  72. De Francisco, D. The Child Dream and the Child Transference The Journal of the American Psychoanalytic Association Vol. 34, No. 1, pp. 93-121, 1986.

  73. Cohn, J.B.; Bowden, C.L.; Fisher, J.G. and Rodos, J.J. Double-Blind Comparison of Buspirone and Clorazepate in Anxious Outpatients. Amer. J. Med. 80(3B): 10-16, 1986.

  74. Wascher, R.A. and Cohn, J.B. Differential Diagnosis of Alzheimer's Disease. Geriat. Med. Today 4(3): 38-48, 1985.

  75. Cohn, J.B. and Wilcox, C.S. Comparison of Fluoxetine, Imipramine and Placebo in Patients with Major Depressive Disorder. Journal of Clinical Psychiatry 46(3): 26-31, 1985. 

  76. Feighner, J.P. and Cohn, J.B. Double-Blind Comparative Trials of Fluoxetine and Doxepin in Geriatric Patients with Major Depressive Disorder. J. Clin. Psychiat. 46(3): 20-25, 1985. 

  77. Cohn, J.B.; Brust, J.; DiSerio, F. and Singer, J. Effect of Bromocriptine Mesylate on Induced Hyperprolactinemia in Stabilized Psychiatric Outpatients Undergoing Neuroleptic Treatment. Neuropsychobiol. 13: 173-179, 1985.

  78. Cohn, J.B.; Wilcox, C.S. and Cohn, J. Treatment of the Anxious Elderly Patient. Geriatric Medicine Today 3(12): 45-55, 1984.

  79. Cohn, J.B. and Wilcox, C.S. Long-Term Comparison of Alprazolam, Lorazepam and Placebo in Patients with an Anxiety Disorder. Pharmacotherapy 4(2): 93-98, 1984.

  80. Cohn, J.B. Double-Blind Crossover Comparison of Triazolam and Lorazepam in Post-Hypnotic State. J. Clin. Psychiat. 45 (3): 104, 1984.

  81. Cohn, J.B.; Varga, L. and Lyford, A. Two-Center Double-Blind Study of Nomifensine, Imipramine and Placebo in Depressed Geriatric Outpatients. J. Clin. Psychiat. 45(4): 213-219, Sec. 2, 1984.

  82. Cohn, J.B. Double-Blind Safety and Efficacy Comparison of Alprazolam and Placebo in the Treatment of Anxiety in Geriatric Patients. Cur. Therap. Res. 35 (1): 100-112, 1984. 

  83. Cohn, J.B. Long- and Short-Acting Benzodiazepines-A Review of Role of Benzodiazepines. Benzodiazepines Divided M.R. Trimble (ed.), John Wiley & Sons, Ltd., pp. 229-236, 1983.

  84. Cohn, J.B. and Wilcox, C.S. Dangerousness as a Standard for Civil Commitment. American Journal of Forensic Psychiatry 1(4): 169-174, 1983.

  85. Cohn, J.B. Triazolam Treatment of Insomnia in Depressed Patients Taking Tricyclics. J. Clin. Psychiat. 44 (11): 401-406, 1983.

  86. Cohn, J.B. Harm to Third Parties in Psychotherapy. Amer. J. Forens. Psychol. 1 (2):38-44, 1983.

  87. Wenger, T.L.; Cohn, J.B. and Bustrack, J. Comparison of Effects of Bupropion and Amitriptyline on Cardiac Conduction in Depressed Patients. J. Clin. Psychiat. 44 (5) (Sec.2): 174-175, 1983. 

  88. Cohn, J.B. and Noble, E.P. Effect of Withdrawing Treatment After Long-Term Administration of Alprazolam, Lorazepam or Placebo in Patients with Anxiety Disorder. Psychopharm. Bull. 19 (4):751-752, 1983.

  89. Pyke, R.; Cohn, J.B.; Feighner, J.P. and Smith, W. Open-Label Studies of Adinazolam in Severe Depression. Psychopharm. Bull. 19 (1): 197-199, 1983.

  90. Cohn, J.B. Geriatric Psychopharmacology Update-1982. Pharmacology for the Family Practitioner Department of Family Practice, University of California, Irvine, 1982.

  91. Cohn, J.B. Psychiatric Emergencies. Emergency Care: Principles and Practices for the EMT Paramedic 2nd Edition, Gazzaniga, A.B., Iseri, L.T. and Baren, M. (eds.), Reston Publication Co., Reston, VA, pp. 551-559, 1982. 

  92. Cohn, J.B. Multicenter, Double-Blind Efficacy and Safety Study Comparing Alprazolam, Diazepam and Placebo in Clinically Anxious Patients. J. Clin. Psychiat. 42: 347-351, 1981. 

  93. De Francisco, D.; Anderson, D.; Pantano, R. and Kline, F. Length of Hospital Stay vs. Rapid Readmission. Hospital and Community Psychiatry Vol. 31, No. 3, pp. 196-197, 1980.
  94. Cohn, J.B. and Gottschalk, L.A. Double-Blind Comparison of Ketazolam and Placebo Using Once-a-Day Dosing, J. Clin. Pharmacol. 20:676-680, 1980.

  95. Dickerson, J.; Bressler, R.; Gelderman, G.A.; Cohn, J.B. and Goldstein, J.A. Bioavailability, Efficacy, Safety Acceptance of Klotrix: A Slow Release Potassium Chloride Supplement. Cur. Ther. Res. 28:340-354, 1980. 

  96. Gottschalk, L.A.; Eckardt, J.; Cohn, J.B.; Terman, S.A. and Wolf, R.J. A Cognitive Impairment Scale Applicable to Verbal Samples and Its Possible Use in Clinical Trials in Patients with Dementia. Psychopharm. Bull. 16 (4):25-27, 1980.

  97. Gottschalk, L.A. and Cohn, J.B. Studies of Cognitive Function as Influenced by Administration of Haloperidol or Diazepam in Detoxification of Active Alcoholics. Psychopharm. Bull. 16 (2):55-56, 1980. 

  98. Cohn, J.B. and Gottschalk, L.A. Critique of the Guidelines for Clinical Evaluation of Anti-Anxiety Drugs. Meth. Find. Exptl. Clin. Pharmacol. 1:313-315, 1979. 

  99. Gottschalk, L.A. and Cohn, J.B. Studies of Cognitive Function as Influenced by Administration of Haloperidol or Diazepam in Detoxification of Acute Alcoholics. Meth. Find. Exptl. Clin. Pharmacol. 1:51-61, 1979.

  100. Gottschalk, L.A.; Mennuti, S.A. and Cohn, J.B. Thioridazine Plasma Levels and Clinical Response in Five Schizophrenic Patients Receiving Daily Oral Medication: Correlations and Prediction of Clinical Response. Pharmacokinetics of Psychoactive Drugs: Further Studies, Gottschalk, L.A. (ed.), Spectrum Publications, Inc., New York, pp. 83-95, 1979.

  101. Gottschalk, L.A. and Cohn, J.B. The Relationship of Diazepam and Ketazolam Blood Levels to Anxiety and Hostility in Chronic Alcoholics. Psychopharm. Bull. 14 (3):39-43, 1978. 

  102. Gazzaniga, A.B.; Webb, S.F.; Pfeffer, R.I.; Valenta, L.J.; Pelot, D.; Fairshter, R.D.; Vaziri, N.D. and Cohn, J.B. Emergency Medical Conditions. Emergency Care: Principles and Practices for the EMT Paramedic, Gazzaniga, A.B., Iseri, L.T., and Baren, M. (eds.), Reston Publication Co., pp. 451-525, 1978. 

  103. Heiser, J.F. and De Francisco, D. "The Treatment of Pathological Panic States with Propanolol," American Journal of Psychiatry Vol. 133, pp. 1390-1394, 1976. 

  104. Pattison, E.M.; De Francisco, D.; Franzier, H.; Wood, P.E. and Crowder, J. "A Psychosocial Kinship Model for Family Therapy," The American Journal of Psychiatry 132:12, December 1975.